FLUDOX-200
MRP: 6,500
Packaging: 1x34
Pack Type: tablet
Composition:
Favipiravir 200mg
Indication:
For Treatment of mild moderate cases of COVID-19
Description:
Favipiravir 200 mg is an oral antiviral medication originally developed for influenza viruses. It is a RNA polymerase inhibitor, which means it prevents the replication of viral RNA inside infected cells. During the COVID-19 pandemic, it was repurposed under emergency use authorization in several countries for mild to moderate COVID-19 infections.
Favipiravir is most effective when administered early in the course of viral infections. It helps reduce the viral load, shorten symptom duration, and minimize complications. It should only be used under medical supervision and is not a first-line drug for severe infections.
Tags:
- Broad-spectrum antiviral targeting RNA viruses
- Helps reduce viral load in mild to moderate infections
- Shortens recovery time
- Oral formulation for ease of use
- Used under emergency protocols during viral outbreaks
Usage Information
Dosage
Adults: Common regimen is 1800 mg twice daily on Day 1, followed by 800 mg twice daily from Day 2 to Day 14 Must be taken after meals with water Dosage may vary by condition and doctor's advice Complete full course even if symptoms improve
Side Effects
Elevated uric acid levels Liver enzyme abnormalities Diarrhea, nausea, or vomiting Dizziness or fatigue Rare: psychiatric symptoms, altered mood
Contraindications
Pregnancy and breastfeeding History of gout or hyperuricemia Severe liver or kidney dysfunction Use with caution in elderly and those on multiple medications Not recommended for asymptomatic COVID-19 cases
Availability
Favipiravir 200 mg tablet uses Antiviral for COVID-19 treatment Favipiravir dosage for flu Favipiravir side effects Favipiravir mechanism of action Oral antiviral drug for influenza Favipiravir tablet price Emergency use antiviral medication Favipiravir dosage in adults Favipiravir safety and efficacy